Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human CD300e/LMIR6 Antibody, R&D Systems™

Rat Monoclonal Antibody
Supplier: R&D Systems MAB2705
This item is not returnable.
View return policy
Description
CD300e/LMIR6 Monoclonal specifically detects CD300e/LMIR6 in Human samples. It is validated for Western Blot, Flow Cytometry, CyTOF-ready.Specifications
CD300e/LMIR6 | |
Monoclonal | |
LYOPH | |
Western Blot 1 ug/mL, Flow Cytometry 2.5 ug/10^6 cells, CyTOF-ready | |
CD300 antigen like family member E, CD300 antigen-like family member E, CD300e, CD300e antigenPIgR-2, CD300e molecule, CD300LE, CD300LEPIgR2, CLM2, CLM-2, CLM2CMRF35-A5, CMRF35A5, CMRF35-like molecule 2, Immune receptor expressed on myeloid cells 2, IREM-2, IREM2IREM-2, LMIR6, Poly-Ig receptor 2, Polymeric immunoglobulin receptor 2 | |
Rat | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
342510 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2a |
Western Blot, Flow Cytometry, CyTOF | |
233810 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
CD300E | |
Y3 rat myeloid cell line transfected with human CD300e/LMIR6 | |
100 μg | |
Primary | |
Detects human CD300e/LMIR6 in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant human LMIR1, 2, 3, 4, or 5 is observed. | |
Human | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction